Mix-and-match trial is actually precision medicine

August 20, 2015

New type of trial shows promise for several cancers

Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation.

By VUMC News and Communications

February 16, 2023

Tindle authors NCI guidance on treatment of cancer patients who smoke

Vanderbilt’s Hilary Tindle, MD, MPH, was one of the key contributors to the new Tobacco Control Monograph from the National Cancer Institute.

By Tom Wilemon

August 20, 2024

VUMC participating in clinical trial of novel heart failure treatment  

Patients with a form of heart failure called HFpEF may breathe normally at rest but quickly become breathless with physical activity. The study will test an atrial shunt to relieve high pressure in the heart.

By Craig Boerner